|
US2528378A
(en)
|
1947-09-20 |
1950-10-31 |
John J Mccabe Jr |
Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
|
|
NL272723A
(https=)
|
1951-05-31 |
|
|
|
|
US2675619A
(en)
|
1952-05-31 |
1954-04-20 |
Mcbee Co |
Drafting instrument
|
|
US2738303A
(en)
|
1952-07-18 |
1956-03-13 |
Smith Kline French Lab |
Sympathomimetic preparation
|
|
US2996431A
(en)
|
1953-12-16 |
1961-08-15 |
Barry Richard Henry |
Friable tablet and process for manufacturing same
|
|
US2781354A
(en)
|
1956-03-26 |
1957-02-12 |
John J Mccabe Jr |
Imidazoline derivatives and process
|
|
US3036118A
(en)
|
1957-09-11 |
1962-05-22 |
Wyandotte Chemicals Corp |
Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
|
|
US2979578A
(en)
|
1958-10-30 |
1961-04-11 |
Litton Systems Inc |
Omnipositional rotary switch
|
|
US3139383A
(en)
|
1961-06-26 |
1964-06-30 |
Norton Co |
Encapsulated time release pellets and method for encapsulating the same
|
|
NL130291C
(https=)
|
1964-01-02 |
|
|
|
|
US3829506A
(en)
|
1971-06-01 |
1974-08-13 |
Basf Wyandotte Corp |
Biodegradable surface active agents having good foam properties and foam stabilizing characteristics
|
|
US3962414A
(en)
|
1972-04-27 |
1976-06-08 |
Alza Corporation |
Structured bioerodible drug delivery device
|
|
US3811444A
(en)
|
1972-12-27 |
1974-05-21 |
Alza Corp |
Bioerodible ocular device
|
|
DE2336218C3
(de)
|
1973-07-17 |
1985-11-14 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Orale Arzneiform
|
|
US3992518A
(en)
|
1974-10-24 |
1976-11-16 |
G. D. Searle & Co. |
Method for making a microsealed delivery device
|
|
US4093709A
(en)
|
1975-01-28 |
1978-06-06 |
Alza Corporation |
Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
|
|
US4079038A
(en)
|
1976-03-05 |
1978-03-14 |
Alza Corporation |
Poly(carbonates)
|
|
US4066747A
(en)
|
1976-04-08 |
1978-01-03 |
Alza Corporation |
Polymeric orthoesters housing beneficial drug for controlled release therefrom
|
|
US4070347A
(en)
|
1976-08-16 |
1978-01-24 |
Alza Corporation |
Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
|
|
US4290426A
(en)
|
1978-05-04 |
1981-09-22 |
Alza Corporation |
Dispenser for dispensing beneficial agent
|
|
US4434153A
(en)
|
1982-03-22 |
1984-02-28 |
Alza Corporation |
Drug delivery system comprising a reservoir containing a plurality of tiny pills
|
|
US4721613A
(en)
|
1982-12-13 |
1988-01-26 |
Alza Corporation |
Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
|
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
|
US4727064A
(en)
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US4752470A
(en)
|
1986-11-24 |
1988-06-21 |
Mehta Atul M |
Controlled release indomethacin
|
|
US4853229A
(en)
|
1987-10-26 |
1989-08-01 |
Alza Corporation |
Method for adminstering tiny pills
|
|
US5180589A
(en)
|
1988-03-31 |
1993-01-19 |
E. R. Squibb & Sons, Inc. |
Pravastatin pharmaceuatical compositions having good stability
|
|
US5030447A
(en)
|
1988-03-31 |
1991-07-09 |
E. R. Squibb & Sons, Inc. |
Pharmaceutical compositions having good stability
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US4997904A
(en)
|
1989-08-25 |
1991-03-05 |
Nova Pharmaceutical Corporation |
Aromatic polyanhydride compositions
|
|
US5175235A
(en)
|
1990-06-04 |
1992-12-29 |
Nova Pharmaceutical Corporation |
Branched polyanhydrides
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
US5286497A
(en)
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
|
US5326570A
(en)
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
|
US5225202A
(en)
|
1991-09-30 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Enteric coated pharmaceutical compositions
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5256440A
(en)
|
1992-06-22 |
1993-10-26 |
Merck & Co., Inc. |
Process for producing a tablet core aperture
|
|
US5500227A
(en)
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
NZ270078A
(en)
|
1994-12-06 |
1998-05-27 |
Bernard Charles Sherman |
Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
|
|
US5773019A
(en)
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US5998380A
(en)
|
1995-10-13 |
1999-12-07 |
New England Medical Center Hospitals, Inc. |
Treatment of migraine
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5985312A
(en)
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
US6159501A
(en)
*
|
1996-03-08 |
2000-12-12 |
Nycomed Danmark A/S |
Modified release multiple-units dosage composition for release of opioid compounds
|
|
US5955096A
(en)
|
1996-06-25 |
1999-09-21 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
|
US5753693A
(en)
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
|
|
GB9711643D0
(en)
|
1997-06-05 |
1997-07-30 |
Janssen Pharmaceutica Nv |
Glass thermoplastic systems
|
|
US5760007A
(en)
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US5935933A
(en)
|
1997-07-16 |
1999-08-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
|
US20040028735A1
(en)
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
|
UA65607C2
(uk)
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
|
US6235311B1
(en)
|
1998-03-18 |
2001-05-22 |
Bristol-Myers Squibb Company |
Pharmaceutical composition containing a combination of a statin and aspirin and method
|
|
US6524620B2
(en)
*
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
|
EP1126826B3
(en)
*
|
1998-11-02 |
2019-05-15 |
Alkermes Pharma Ireland Limited |
Multiparticulate modified release composition of methylphenidate
|
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US6528090B2
(en)
|
1998-12-18 |
2003-03-04 |
Abbott Laboratories |
Controlled release formulation of divalproex sodium
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
ES2228465T3
(es)
|
1999-01-19 |
2005-04-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Uso derivados anticonvulsionantes para el tratamiento de cefaleas en brotes.
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
JP4825353B2
(ja)
|
1999-04-08 |
2011-11-30 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
血圧を下げることに有用な抗痙攣薬誘導体
|
|
US7056890B2
(en)
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
HUP0203198A3
(en)
|
1999-08-20 |
2005-07-28 |
Ortho Mcneil Pharm Inc |
Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use
|
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
SE0000601D0
(sv)
|
2000-02-24 |
2000-02-24 |
Jan Hedner |
Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
NZ523531A
(en)
|
2000-07-07 |
2005-07-29 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X
|
|
US6191117B1
(en)
|
2000-07-10 |
2001-02-20 |
Walter E. Kozachuk |
Methods of producing weight loss and treatment of obesity
|
|
US6344215B1
(en)
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
MXPA03003870A
(es)
|
2000-10-30 |
2004-08-12 |
Johnson & Johnson |
Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
|
|
US20020082222A1
(en)
|
2000-11-30 |
2002-06-27 |
Shapira Nathan Andrew |
Treatments for neurogenetic disorders, impulse control disorder, and wound healing
|
|
TWI321054B
(en)
|
2000-12-19 |
2010-03-01 |
California Inst Of Techn |
Compositions containing inclusion complexes
|
|
IL159715A0
(en)
|
2001-07-10 |
2004-06-20 |
Teva Pharma |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
|
US6500454B1
(en)
|
2001-10-04 |
2002-12-31 |
Eurand Pharmaceuticals Ltd. |
Timed, sustained release systems for propranolol
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US20030072802A1
(en)
|
2001-10-11 |
2003-04-17 |
R.T. Alamo Ventures, Inc. |
Sustained release topiramate
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US7815936B2
(en)
|
2001-10-30 |
2010-10-19 |
Evonik Degussa Gmbh |
Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
|
|
CA2470495A1
(en)
|
2001-12-24 |
2003-07-17 |
Teva Pharmaceutical Industries Ltd. |
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
|
|
US20040052843A1
(en)
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
WO2003072138A1
(en)
|
2002-02-26 |
2003-09-04 |
Ortho-Mcneil Pharmaceutical Inc. |
Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
|
|
AU2003231777C1
(en)
|
2002-04-29 |
2009-10-29 |
Supernus Pharmaceuticals, Inc. |
Pharmaceutical formulations with improved bioavailability
|
|
AR039744A1
(es)
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
AU2003263760A1
(en)
|
2002-06-27 |
2004-01-19 |
The General Hospital Corporation |
Methods for the treatment or prevention of obesity
|
|
NZ537543A
(en)
|
2002-07-29 |
2007-08-31 |
Alza Corp |
Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
BR0314036A
(pt)
|
2002-09-04 |
2005-07-12 |
Ranbaxy Lab Ltd |
Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação
|
|
US20040132826A1
(en)
|
2002-10-25 |
2004-07-08 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
AU2002350719A1
(en)
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
MXPA05006210A
(es)
|
2002-12-13 |
2005-08-19 |
Cilag Ag |
Preparaciones de liberacion controlada que comprenden tramadol y topiramato.
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
US7390505B2
(en)
|
2003-01-31 |
2008-06-24 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
|
US20060210633A1
(en)
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
|
WO2004091483A2
(en)
|
2003-04-07 |
2004-10-28 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
AU2004264316A1
(en)
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
|
MXPA06002067A
(es)
|
2003-08-22 |
2006-08-11 |
Johnson & Johnson |
Suministro gradual de topiramato durante periodo prolongado.
|
|
AU2004268661A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
|
US7737133B2
(en)
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
|
US7611728B2
(en)
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
MXPA06003453A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
|
DK2210605T3
(en)
|
2003-11-04 |
2017-05-22 |
Tcd Royalty Sub Llc |
Daily single dose doses of trospium.
|
|
EP1682092A2
(en)
|
2003-11-13 |
2006-07-26 |
Alza Corporation |
Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer
|
|
US7387793B2
(en)
*
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
|
JP2007511519A
(ja)
|
2003-11-14 |
2007-05-10 |
アルザ・コーポレーシヨン |
液状投薬形態物におけるトピラメートの制御放出
|
|
US7470435B2
(en)
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
|
EP1706098A4
(en)
|
2003-11-26 |
2012-08-15 |
Supernus Pharmaceuticals Inc |
MICRO-LAYER SYSTEMS FOR THE TRANSPORT OF LIPOPHILES AND BZW. HYDROPHOBIC COMPOUNDS
|
|
JP2007516297A
(ja)
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
|
JP2007517063A
(ja)
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
トピラメートの新規な薬剤組成物および剤形
|
|
CA2556214A1
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
ES2241478B1
(es)
*
|
2004-02-13 |
2006-11-16 |
Lacer S.A. |
Preparacion farmaceutica para la liberacion sostenida de un principio farmaceuticamente activo.
|
|
US20050220596A1
(en)
|
2004-03-30 |
2005-10-06 |
Cnh America Llc |
Method and apparatus for hydraulically produced ground following of an unloading ramp for a cotton harvester
|
|
EP1807192B1
(en)
*
|
2004-07-02 |
2010-02-17 |
The University Court Of The University Of Edinburgh |
Fluid-bicontinuous particle-stabilised gels
|
|
US20070224281A1
(en)
*
|
2004-07-22 |
2007-09-27 |
Amorepacific Corporation |
Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof
|
|
JP2008509144A
(ja)
|
2004-08-04 |
2008-03-27 |
アルザ・コーポレーシヨン |
上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
|
|
CA2582255A1
(en)
|
2004-08-30 |
2006-08-08 |
Lunamed, Inc. |
4-phenylbutyric acid controlled-release formulations for therapeutic use
|
|
US20060105045A1
(en)
|
2004-11-08 |
2006-05-18 |
Buchanan Charles M |
Cyclodextrin solubilizers for liquid and semi-solid formulations
|
|
US20060121112A1
(en)
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
|
GB2422149A
(en)
|
2005-01-14 |
2006-07-19 |
Portela & Ca Sa |
Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
|
|
US20060233892A1
(en)
|
2005-04-19 |
2006-10-19 |
Curt Hendrix |
Topiramate compositions for treatment of headache
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
US8491929B2
(en)
|
2005-06-23 |
2013-07-23 |
Vaunnex Inc. |
Bioadhesive polymers
|
|
US8784886B2
(en)
|
2006-03-09 |
2014-07-22 |
GlaxoSmithKline, LLC |
Coating capsules with active pharmaceutical ingredients
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
WO2008027557A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Spherics, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
|
DK2089005T3
(da)
|
2006-11-09 |
2010-07-19 |
Orexigen Therapeutics Inc |
Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
|
|
ES2555066T3
(es)
|
2006-11-17 |
2015-12-28 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de liberación sostenida de topiramato
|
|
ES2645719T3
(es)
|
2006-12-04 |
2017-12-07 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de topiramato de liberación inmediata mejoradas
|